These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2690768)

  • 1. Randomized study of danazol vs. placebo in myelodysplastic syndromes.
    Avilés A; Rubio ME; Gómez J; Medina ML; González-Llaven J
    Arch Invest Med (Mex); 1989; 20(2):183-8. PubMed ID: 2690768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of danazol in myelodysplastic syndromes.
    Marini B; Bassan R; Barbui T
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1481-9. PubMed ID: 3181270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Danazol in the treatment of myelodysplastic syndromes.
    Buzaid AC; Garewal HS; Lippman SM; Durie BG; Katakkar SB; Greenberg BR
    Eur J Haematol; 1987 Oct; 39(4):346-8. PubMed ID: 3319676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of unexplained infertility with danazol.
    van Dijk JG; Frolich M; Brand EC; van Hall EV
    Postgrad Med J; 1979; 55 Suppl 5():79-80. PubMed ID: 395525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Danazol treatment of chronic cystic mastopathy: a clinical and hormonal evaluation.
    Dhont M; Delbeke L; van Eyck J; Voorhoof L
    Postgrad Med J; 1979; 55 Suppl 5():66-70. PubMed ID: 395523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premenstrual syndrome: beneficial effects of periodic, low-dose danazol.
    Sarno AP; Miller EJ; Lundblad EG
    Obstet Gynecol; 1987 Jul; 70(1):33-6. PubMed ID: 3299177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of danazol and placebo in the treatment of adult idiopathic gynaecomastia: results of a prospective study in 55 patients.
    Jones DJ; Holt SD; Surtees P; Davison DJ; Coptcoat MJ
    Ann R Coll Surg Engl; 1990 Sep; 72(5):296-8. PubMed ID: 2221763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of 76 patients with myelodysplastic syndromes treated with danazol.
    Chabannon C; Molina L; Pégourié-Bandelier B; Bost M; Léger J; Hollard D
    Cancer; 1994 Jun; 73(12):3073-80. PubMed ID: 8200005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of myelodysplastic syndromes with danazol].
    Aviles A; García LD; Romero N; Tripp F; González-Llaven J
    Arch Invest Med (Mex); 1988; 19(1):73-7. PubMed ID: 3228341
    [No Abstract]   [Full Text] [Related]  

  • 10. Danazol and myelodysplastic syndromes.
    Kornberg A; Yona R; Iuklea S; Kaufman S
    Ann Intern Med; 1986 Mar; 104(3):445-6. PubMed ID: 3946991
    [No Abstract]   [Full Text] [Related]  

  • 11. [Danazol in the treatment of acute leukemic transformation of myelodysplastic syndromes].
    Sans-Sabrafen J; Martín Casellas E; Salinas Argente R
    Med Clin (Barc); 1987 Nov; 89(17):756. PubMed ID: 3695720
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized study of 13-cis retinoic acid v placebo in the myelodysplastic disorders.
    Koeffler HP; Heitjan D; Mertelsmann R; Kolitz JE; Schulman P; Itri L; Gunter P; Besa E
    Blood; 1988 Mar; 71(3):703-8. PubMed ID: 3278754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes.
    Kao JM; McMillan A; Greenberg PL
    Am J Hematol; 2008 Oct; 83(10):765-70. PubMed ID: 18645988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danazol for the treatment of thrombocytopenia in patients with myelodysplastic syndrome.
    Chan G; DiVenuti G; Miller K
    Am J Hematol; 2002 Nov; 71(3):166-71. PubMed ID: 12410570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes].
    García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F
    Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of danazol in the treatment of painful benign breast disease: preliminary results.
    Mansel RE; Wisbey JR; Hughes LE
    Postgrad Med J; 1979; 55 Suppl 5():61-5. PubMed ID: 395522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia.
    Nimer SD; Paquette RL; Ireland P; Resta D; Young D; Golde DW
    Exp Hematol; 1994 Aug; 22(9):875-80. PubMed ID: 8062886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Danazol therapy in myelodysplastic syndromes.
    Pozzato G; Franzin F; Moretti M; Campanacci L
    Haematologica; 1992; 77(1):96. PubMed ID: 1398293
    [No Abstract]   [Full Text] [Related]  

  • 20. Danazol therapy in haemophilia.
    Heaton DC; Wyld PJ; Conder JL
    N Z Med J; 1986 Mar; 99(798):185-7. PubMed ID: 3517712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.